Document is current

Any future updates will be listed below

Retraction Note: Receptor tyrosine kinase inhibitor Sunitinib and integrin antagonist peptide HM-3 show similar lipid raft dependent biphasic regulation of tumor angiogenesis and metastasis

Crossref DOI link: https://doi.org/10.1186/S13046-020-1538-8

Published Online: 2020-02-17

Published Print: 2020-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

About CrossMark